Life Sciences Archive » August, 2010

Life Sciences - August, 2010

172 articles

• Remand Bid Defeated In Propofol Class Action
• Prempro MDL Judge Nixes Plaintiffs' Expert Testimony
• Most Admired Attys: Skadden's Sheila Birnbaum
• KPMG Settles Accounting Fraud Class Action
• Ex-Pfizer Worker Loses Bid To Revive ERISA Dispute
• Baxter Fined $4.4M For Bundling IV Fluid Contracts
• J&J Unit Faces Suits Over Recalled Hip Implant
• In 3 Pa. Rulings, Pharma Loses A Little But Gains A Lot
• Medicare Part D Fraud Claims Preempted: 9th Circ.
• Most Admired Attys: Reed Smith's Michael Brown
• Jazz, Anchen Strike Deal Over Generic Luvox
• 2nd Circ. Nixes RxUSA's Bid To Revive Antitrust Suit
• Salix Settles With Novel Over Generic MoviPrep
• Eisai Wins Dismissal Of Apotex's Suit Over Aricept
• Trade Group Backs Matrixx On Side-Effect Reporting
• Avandia Probes Lead To ERISA Class Suit Against GSK
• Sanofi Hints At Hostile Bid After Genzyme Rejects Offer
• CVS Settles Mass. Drug Overcharge Claims For $2.7M
• MDL Judge Nixes Global Zicam Settlement
• Merck Faces Contract, IP Suit Over Dr. Scholl's Inserts
• Cooley Reps Bravo Health In $545M HealthSpring Buy
• Lilly Gets Longer Reprieve On Strattera Appeal
• Dentsply Loses Bid To Nab $4M In Contract Spat
• The Legal Market In Transition
• Most Admired Attys: Cooley's Anthony Stiegler
• Bayer, Bic Escape False Patent Marking Suits
• Ex-MoFo Partner Arrested For Bilking Schools, Insurers
• US, St. Jude In Talks To End Qui Tam Kickback Suit
• Sanofi Fails To Nix Approval For Generic Lovenox
• Novartis Cuts Patent From Suit Over Hemophilia Drugs
• LEO Pharma Fights Tolmar's Taclonex ANDA
• Stryker To Pay $1.4M Over Bone Protein Marketing
• Conn. Probes Rite Aid Over Discount Drug Price Hikes
• Export Council Gets Moving On US Trade Initiatives
• Rigel Shareholders Again Lose Suit Over Arthritis Drug
• Mexico OKs Mexichem-Cydsa Deal With Conditions
• AGA Says WL Gore Infringes Heart Device Patent
• Stryker To Snap Up Gaymar Industries For $150M
• Boniva ANDAs Infringe Roche Patent: Judge
• Blood Reagent Price-Fixing MDL Survives Dismissal Bid
• Sweat The Small Stuff — Nanotech Insurance Issues
• FDA Warns J&J Unit Over Joint Product Marketing
• 2nd Circ. Judge Hints At Antitrust Motive In RxUSA Suit
• Most Admired Attys: Durie Tangri's Mark Lemley
• Discovery To Proceed In Signalife Securities Action
• AstraZeneca UK Workers To Strike Over Pensions
• Biolitec Wins Partial Toss Of Medical Laser Patent Suit
• FDA Warns AMRI Over Contamination At Mass. Plant
• Schering Loses Round In Sunscreen Injunction Bid
• EVM Lobs Patent Suit At Boston Sci, Cordis, Abbott
• J&J Recalls Acuvue Lenses In Asia, Europe
• Most Admired Attys: WilmerHale's Bill Lee
• Schering Goes After Impax Over Vytorin ANDA
• DLA Piper Adds 6 Hogan Lovells IP Litigators In LA
• Pfizer Wants Dozens Tossed From Bextra MDL
• Cephalon Sues Apotex To Block Generic Nuvigil
• Wockhardt Exits Sepracor's Lunesta Patent Suit
• Zicam Maker Settles 18 Economic Injury Suits
• Mirapex Compulsive Gambling Suits To Remain MDL
• Premier's Arbitration Bid Nixed In Rival's Antitrust Suit
• Mylan Violated Mirapex Patent, Judge Rules
• Lilly Wins Short Ban On Generic Strattera
• Blank Rome Out As Counsel In Contract Suit V. J&J Unit
• Aurobindo, Torrent Infringe Sanofi's Uroxatral IP: Judge
• Understanding NC V. Tennessee Valley Authority
• Novartis Fights Alexion's Soliris Patent
• Prempro Plaintiffs Eye New Trial After Wyeth Win
• Inequitable Conduct Pleadings, Post-Exergen
• 6th Circ. Partially Revives Wyeth Redux Liability Suit
• 8th Circ. Nixes Hospital Antitrust Suit Against CR Bard
• Perrigo Sued Over ANDA For Psoriasis Shampoo
• Novartis Inks $670M Deal For Kidney Treatment Drug
• Most Admired Attys: Covington's Deborah Garza
• FDA, Rising? Oversight May Increase for Devices, Drugs
• Schering Shareholders Win Access To Board Notes
• Conceptus, Hologic Nix Non-IP Claims In Patent Spat
• Sanofi Wants FDA Approval Of Generic Lovenox Nixed
• Pa. Court Refuses To Nix Counsel In Risperdal Suit
• Watson CEO Must Face FTC Subpoena: Judge
• HealthGrades Faces Shareholder Suit Over Vestar Deal
• Watson Hit With False Marking Suit Over Androderm
• Aspen Snaps Up Sigma Pharma Unit In $816M Deal
• Corporate Piracy Efforts: Cost Center Or Profit Center?
• Lilly Seeks To Block Generic Strattera Amid Appeal
• FDA Threatens To Pull Blood Pressure Drug
• FTC Asks Novartis To Shed Drug For Alcon Deal
• Fried Frank, Howrey Rep Medco In $730M UBC Deal
• Roche Prevails In HPV-Test License Spat
• Most Admired Attys: McKool Smith's Sam Baxter
• Arguments Against Fixed Fees, And Why They're Myths
• KeyCorp ERISA Stock-Drop Class Action Nixed
• Biopsy Tool Patent Not Infringed: Fed. Circ.
• Bayer Faces False Marking Suit Over Glucose Monitors
• Plaintiffs' Atty Barred From Using Leaked Zyprexa Docs
• Pfizer Targets Actavis Over Generic Lipitor
• GSK Epilepsy, Bipolar Drug Linked To Meningitis
• Lilly's Patent For ADHD Drug Strattera Found Invalid
• Ex-St. Jude Exec Can't Work At Medtronic Until Nov.
• Study Contests Savings From Pay-For-Delay Bill
• Infringement Claims Nixed In VNUS Vein Treatment Suit
• 7th Circ. Sides With McNeil In $3.5M Motrin Allergy Case
• CardioNet Wins Dismissal Of Investor Class Action
• A Snapshot Of International Antitrust Developments
• J&J Faces Inquiries From State AGs Over Recalls
• Challenging CT Scans In Medical Monitoring Claims
• FDA Warns CorePharma Over Manufacturing Issues
• K&L Gates Nabs IP Corporate Partner From Foley
• Sanofi Fails To Shake Eisai's Lovenox Antitrust Suit
• Bard Hits Atrium, Endologix With Graft Patent Suit
• Novacare Recalls Supplements With ED Drug
• Ikaria Recalls Inomax DS Drug Delivery Systems
• Alphatec Hit With Securities Suit Over French Buy
• Conceptus Falsely Marked Sterilization Kit, Rival Says
• 3rd Circ. Revives Blueberry Farmers' Suit V. Novartis
• Patients Seek Cash From Troutman, Nursing Home Spat
• Feds Eyeing SciClone For Possible FCPA Violations
• AstraZeneca To Pay $198M To End Seroquel Suits
• FTC May Have Spilled Watson's Secrets, CEO Says
• Lupin Unit Sues Ranbaxy Over Antara ANDA
• Intervet Plan For Quiet Vetsulin Settlements Thwarted
• Is It Time For 'Total Recall' Of Medical Products?
• Skadden Advises Endo In $168M Penwest Buy
• EU OKs Novartis-Alcon Deal Following Sale Of Assets
• Best Medical Sues Ex-Workers, Accuray Over Patent
• Feds Intervene In St. Jude Kickback Suit
• FDA Warns Doctors Of Retrievable IVC Filter Risks
• FDA Blasts Novartis Over Drug Info On Facebook
• Teva Avoids Injunction In Alcon's Vigamox IP Suit
• Canada Clears Novartis-Alcon Deal With Divestitures
• Novo Wins Sex Harassment Suit Before 11th Circ.
• DLA Piper Names 2 Chairs To Succeed Leadership
• SEC, DOJ Launch FCPA Probe Into Merck
• FDA Could Warn Gilead For Manufacturing Issues
• Glenmark Settles Lunesta Patent Spat With Sepracor
• FTC Seeks More Info On $3.4B Grifols-Talecris Deal
• An Overview Of Section 337 Litigation Before The ITC
• Feds Want In On St. Jude Kickback Scheme Suit
• Invacare Hits Rival With 337 Suit Over Medical Beds
• $10M Verdict For Accutane User Nixed On Appeal
• Ex-Bristol-Myers Employee's Title VII Suit Revived
• Congress Urges FDA To Seek Sizable Budget Boost
• Bayer Wins Toss Of Third-Party Payors Suit In Yaz MDL
• Fed. Circ. Vacates Perrigo Win In Mucinex ANDA Spat
• Judge Won't Invalidate VNUS Laser Treatment Patents
• Fed. Circ. Revives Pig Virus Patent Claims V. Intervet
• Weight-Loss Pill Fraud Class Action Eighty-Sixed
• Daiichi, Apotex Settle Patent Suit Over Evoxac ANDA
• Sanofi's $24.2M Sex Bias Settlement Approved
• MDCO Wins 2nd Suit Over Angiomax Patent Extension
• Patent Examiner Interviews Post-Bilski
• Tiny Particles, Big Coverage Issues?
• Fed. Circ. Says Cordis Didn't Infringe Stent Patents
• Cuomo Probes Predatory Health Care Lending Claims
• FCBA Weighs In On Recusal In Myriad Gene Patent Suit
• AstraZeneca Puts 4K Seroquel Injury Claims To Bed
• EU OKs $4.9B Teva-Ratiopharm Deal, With Caveats
• Squire Sanders Adds 2 Life Sciences Gurus
• New Trial Ordered In $4M Wyeth Retaliation Suit
• FDA Looks To Streamline Device Approval Process
• 3rd Circ. Upholds Cyberonics Win In Liability Case
• Eisai Calls For Tough Inequitable Conduct Standard
• Wal-Mart, J&J Get Baby Shampoo Class Suits Tossed
• Employer, Beware: Outside Sales Reps May Require OT
• 11th Circ. Nixes Bio-Med Receiver's Bid To Clear Name
• Fed. Circ. Rebuffs Attack On Skelaxin Invalidity Ruling
• GSK Sets Up Fund To Resolve Poligrip Suits
• Sidley Austin Adds Ex-FDA Deputy Chief Counsel
• Edwards Angell Lures Morgan Lewis IP Partner
• Pfizer Win In Vaccine-Related Cancer Suit Overturned
• What's Causing The Rise In Pregnancy Bias Claims
• Ineos To Sell Films Business To Bilcare For €100M
• The Genomics And Personalized Medicine Act Of 2010